Evaluation of concurrent and adjuvant carboplatin with radiation therapy for locally advanced cervical cancer.

Objective: To analyze the toxicity profile and long-term outcomes of patients receiving carboplatin with concurrent radiation for locally advanced cervical cancer.

Methods: A retrospective study was performed to identify patients treated with carboplatin and concurrent radiation therapy for locally advanced cervical cancer with a minimum follow-up period of 24 months. Records were reviewed for demographic data, chemotherapy doses, toxicities, and survival outcomes.